Trials / Not Yet Recruiting
Not Yet RecruitingNCT06195163
TRAP Study: Testosterone for Androgen Receptor Polymorphism
Transdermal Testosterone Pretreatment in Poor Responders With Androgen Receptor Polymorphism Undergoing ICSI: A Randomized Clinical Investigation.
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Instituto Bernabeu · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To determine whether pretreatment with transdermal testosterone increases the number of cumulus-oocyte complexes (COCs) obtained after ovarian stimulation by more than 1.5 in patients with low ovarian reserve and androgen receptor polymorphism undergoing intracytoplasmic sperm injection (ICSI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Transdermal Gel in Sachet Dosage Form | Transdermal testosterone gel application prior to ovarian stimulation in the study group. |
| DRUG | No pretreatment | No pretreatment prior to the ovarian stimulation in the control group. |
Timeline
- Start date
- 2025-09-30
- Primary completion
- 2026-09-30
- Completion
- 2026-12-31
- First posted
- 2024-01-08
- Last updated
- 2025-05-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06195163. Inclusion in this directory is not an endorsement.